Round white pills on a wooden surface
No Reduction in COVID-19 Hospitalizations, Deaths with Ivermectin
The ACTIV-6 trial reports that people who took the drug for three days may have spent slightly less time feeling unwell with SARS-CoV-2, but fails to find differences in disease progression between the treatment and placebo groups.
No Reduction in COVID-19 Hospitalizations, Deaths with Ivermectin
No Reduction in COVID-19 Hospitalizations, Deaths with Ivermectin

The ACTIV-6 trial reports that people who took the drug for three days may have spent slightly less time feeling unwell with SARS-CoV-2, but fails to find differences in disease progression between the treatment and placebo groups.

The ACTIV-6 trial reports that people who took the drug for three days may have spent slightly less time feeling unwell with SARS-CoV-2, but fails to find differences in disease progression between the treatment and placebo groups.

ivermectin
Illustration depicting peers reviewing a paper
Opinion: The Problem with Preprints
Michael Mullins | Nov 1, 2021
Preprints can be valuable additions to the scientific literature. But we must start seeing them as perishable commodities rather than akin to peer-reviewed, published studies.
Blue stethoscope resting on a pile of folders filled with papers
Ivermectin (Still) Lacks Scientific Support as a COVID-19 Drug
Catherine Offord | Aug 2, 2021
A Cochrane review bolsters scientists’ advice that ivermectin should not be used against the disease outside of clinical trials, while a study claiming to have found beneficial effects in patients was withdrawn following allegations of data manipulation.
EXCLUSIVE
Assorted pills and tablets
Frontiers Pulls Special COVID-19 Issue After Content Dispute
Catherine Offord | Apr 28, 2021
The issue’s guest editors resign after falling out with the publisher over the management of papers, including a rejected manuscript on ivermectin, that were submitted for a special issue on drug repurposing for COVID-19.
Frontiers Removes Controversial Ivermectin Paper Pre-Publication
Catherine Offord | Mar 2, 2021
A review article containing contested claims about the tropical medicine drug as a COVID-19 treatment was listed as “provisionally accepted” on the journal’s website before being removed this week.
Special Report
Surgisphere Sows Confusion About Another Unproven COVID-19 Drug
Catherine Offord | Jun 16, 2020
The company behind a now-discredited study on hydroxychloroquine also posted a report that has been cited by Latin American governments recommending ivermectin as a possible coronavirus treatment. Clinicians there say the effects have been extremely damaging.
A Farewell to Parasites
Nsikan Akpan | Sep 1, 2013
Despite a fierce civil war, scientists led a 14-year grassroots campaign that has eradicated a parasitic disease from northern Sudan.
Out of Sight
Nsikan Akpan | Aug 31, 2013
The community-based healthcare effort that helped stamp out river blindness in one area of Sudan
Fighting River Blindness
Nsikan Akpan | Aug 31, 2013
The debilitating parasitic disease, onchocerciasis, is all but vanquished in one corner of Sudan, thanks to a community-wide health effort.